A levitating tattoo in a hepatitis C patient on treatment

Liver Int. 2010 Apr;30(4):583-4. doi: 10.1111/j.1478-3231.2009.02173.x. Epub 2009 Dec 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Biopsy, Needle
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / pathology
  • Humans
  • Immunohistochemistry
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Recombinant Proteins
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use
  • Risk Assessment
  • Sarcoidosis / drug therapy
  • Sarcoidosis / etiology*
  • Sarcoidosis / pathology
  • Skin Diseases / drug therapy
  • Skin Diseases / etiology*
  • Skin Diseases / pathology
  • Steroids / therapeutic use
  • Tattooing / adverse effects*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Steroids
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a